Old Web
English
Sign In
Acemap
>
authorDetail
>
Veronika Opatrna
Veronika Opatrna
University of Ulm
Rituximab
Medicine
Obinutuzumab
Chronic lymphocytic leukemia
Oncology
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
RPS15 mutations and Treatment Outcome in Chronic Lymphocytic Leukemia - Results from the CLL11 Phase III Trial (Chlorambucil (Clb) with or without the Addition of Rituximab (R) or Obinutuzumab (GA101, G)) of the German CLL Study Group
2017
Blood
Sven Estenfelder
Ann-Kathrin Holland-Letz
Eugen Tausch
Sandra Robrecht
Jasmin Bahlo
Valentin Goede
Veronika Opatrna
Matthias Ritgen
Jacques J.M. van Dongen
Anton W. Langerak
Günter Fingerle-Rowson
Michael Kneba
Kirsten Fischer
Michael Hallek
Hartmut Döhner
Stephan Stilgenbauer
Show All
Source
Cite
Save
Citations (0)
Recurrent Gene Mutations and Clinical Outcome in the Context of Lenalidomide Treatment of Relapsed/Refractory CLL — Results from Multicenter Phase II Trial CLL-009
2017
Blood
Veronika Opatrna
Eugen Tausch
Graeme Fraser
Anne-Sophie Michallet
Peter Hillmen
Jan Dürig
Matt Kalaycio
John G. Gribben
Thomas J. Kipps
Brendan Purse
Jennie Zhang
Sabine De Bedout
Asher A. Chanan Khan
Michael Hallek
Clemens-Martin Wendtner
Hartmut Döhner
Stephan Stilgenbauer
Show All
Source
Cite
Save
Citations (1)
Short Telomeres Are Independent Prognostic Factors Associated with Poor Outcome in Chronic Lymphocytic Leukemia (CLL) Treated with Chlorambucil with or without the Addition of Rituximab or Obinutuzumab: Results from CLL11 Trial of the Gcllsg
2017
Blood
Billy Michael Chelliah Jebaraj
Annika Scheffold
Sandra Robrecht
Jasmin Bahlo
Valentin Goede
Eugen Tausch
Sven Estenfelder
Veronika Opatrna
Matthias Ritgen
Jacques J.M. van Dongen
Anton W. Langerak
Günter Fingerle-Rowson
Michael Kneba
Kirsten Fischer
Michael Hallek
Hartmut Döhner
Stephan Stilgenbauer
Show All
Source
Cite
Save
Citations (0)
1